Supernus Pharmaceuticals (SUPN) Change in Taxes (2016 - 2020)

Supernus Pharmaceuticals (SUPN) has 5 years of Change in Taxes data on file, last reported at -$25.1 million in Q3 2020.

• Change in Taxes for Q3 2020 came in at -$25.1 million, down 1268.42% year-over-year; the trailing twelve-month figure through Sep 2020 was -$4.9 million (down 31.72% YoY), and the FY2019 annual result was -$9.9 million, down 178.97% from the prior year.
• Change in Taxes eased to -$25.1 million in Q3 2020 per SUPN's latest filing, from $15.9 million in the prior quarter.
• Over five years, Change in Taxes peaked at $15.9 million in Q2 2020 and troughed at -$25.1 million in Q3 2020.
• A 5-year average of -$5000.0 and a median of $782000.0 in 2016 frame the typical range for Change in Taxes.
• The sharpest annual moves came in 2017 and 2018: Change in Taxes jumped 7481.82% in 2017, then slumped 24176.12% in 2018.
• A 5-year view of Change in Taxes shows it stood at -$804000.0 in 2016, then surged by 1275.25% to $9.4 million in 2017, then plunged by 59.48% to $3.8 million in 2018, then plunged by 162.03% to -$2.4 million in 2019, then slumped by 954.78% to -$25.1 million in 2020.
• Business Quant data shows SUPN's Change in Taxes at -$25.1 million in Q3 2020, $15.9 million in Q2 2020, and $6.7 million in Q1 2020.